The Early Treatment for Retinopathy of Prematurity Study (ETROP)

Status unconfirmed · Phase 2/Phase 3

Conditions studied: Retinopathy of Prematurity

In brief

The goal of the Early Treatment for Retinopathy of Prematurity Study (ETROP) is to test the hypothesis that earlier treatment in carefully selected cases will result in an overall better visual outcome than treatment at the conventional CRYO-ROP threshold point in the disease.

Key facts

Study ID
NCT00027222
Run by
National Eye Institute (NEI)
Starts
2001-10-01
Last updated by the study team
2005-06-24

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.